K-Oxyma Coupling Reagent: Protocol for Peptide Synthesis

K-Oxyma is a potassium salt derivative of Oxyma Pure (ethyl 2-cyano-2-(hydroxyimino)acetate) widely used as a coupling additive in solid-phase peptide synthesis (SPPS) to suppress racemization and enhance coupling efficiency.

Chemical Class

Potassium salt of Oxyma Pure (ethyl 2-cyano-2-(hydroxyimino)acetate, potassium salt)

Primary Application

Coupling additive in solid-phase peptide synthesis (SPPS) for racemization suppression

Aladdin SKU

K468794

Reference (Sigma)

776874

Typical Use Concentration

1–2 equivalents relative to the amino acid activated, used with a carbodiimide or uronium base activator

Solubility

Soluble in DMF and NMP, commonly used solvents in SPPS

Overview and Mechanism

K-Oxyma (potassium Oxyma Pure) is the potassium salt form of ethyl 2-cyano-2-(hydroxyimino)acetate, a benchmark additive for suppressing racemization and side reactions during peptide bond formation. In solid-phase peptide synthesis (SPPS), the active ester intermediate generated between K-Oxyma and the carboxyl-activated amino acid reacts rapidly and selectively with the free amine of the resin-bound peptide chain.

Unlike HOBt (1-hydroxybenzotriazole), K-Oxyma carries no explosion risk and is classified as non-explosive, making it a safer benchtop alternative. Its potassium salt form can improve solubility under certain SPPS conditions compared to the free acid form. The reagent is commonly paired with coupling bases such as DIC (diisopropylcarbodiimide), DCC, or HATU to achieve efficient, low-epimerization amide bond formation.

Materials and Reagents

• K-Oxyma (Aladdin SKU: K468794; ref. Sigma 776874)
• Fmoc-protected amino acids (appropriate for your target sequence)
• Coupling activator: DIC (diisopropylcarbodiimide) or alternative carbodiimide/uronium reagent
• Base: DIPEA (N,N-diisopropylethylamine) or NMM (N-methylmorpholine) as required
• Resin: Rink amide resin, Wang resin, or other SPPS-compatible support
• Solvents: Anhydrous DMF or NMP (peptide-synthesis grade)
• Piperidine (20% v/v in DMF) for Fmoc deprotection
• Kaiser test or chloranil test reagents for coupling monitoring
• Analytical HPLC and mass spectrometry for product verification

Step-by-Step Coupling Protocol

1. Resin swelling: Place the resin in a synthesis vessel and swell in DMF (approximately 10 mL/g resin) for 30 minutes with gentle agitation.
2. Fmoc deprotection: Treat the resin with 20% piperidine in DMF (2 × 5 min) to remove the Fmoc protecting group. Wash thoroughly with DMF (5 × resin volume).
3. Preparation of the activated ester: Dissolve the Fmoc-amino acid (typically 3–5 equivalents relative to resin loading), K-Oxyma (1–2 equivalents relative to amino acid), and DIC (1–2 equivalents relative to amino acid) in a minimum volume of DMF. Pre-activate for 1–2 minutes at room temperature before adding to the resin.
4. Coupling reaction: Add the pre-activated amino acid solution to the resin. Agitate at room temperature for 30–60 minutes (or as optimised for your sequence). For difficult sequences, double coupling or extended reaction times may be required.
5. Coupling monitoring: Remove a small resin sample and perform a Kaiser test (for primary amines) or chloranil test (for secondary amines). A negative result (colourless/yellow beads) confirms complete coupling.
6. Washing: Wash the resin with DMF (3–5 × resin volume) before proceeding to the next deprotection step.
7. Repeat: Cycle through deprotection, coupling, and washing for each amino acid residue in the sequence.
8. Global deprotection and cleavage: After assembly, cleave the peptide from the resin using an appropriate TFA-based cocktail and remove side-chain protecting groups according to the resin and protection scheme used.

Note: All steps should be performed under inert atmosphere conditions when working with moisture-sensitive reagents. Optimise equivalents and coupling times for difficult or aggregation-prone sequences.

Troubleshooting and Optimisation Tips

Incomplete coupling: If Kaiser or chloranil test results are positive after the standard coupling time, perform a double coupling step using fresh reagents. Consider increasing K-Oxyma and DIC equivalents or extending the reaction time to 2 hours.

Aggregation-prone sequences: For hydrophobic or beta-sheet-forming sequences, try switching solvent to NMP or adding chaotropic agents such as LiCl or DMSO to improve resin solvation.

Racemisation concerns: K-Oxyma is specifically designed to minimise epimerisation. Avoid excessive pre-activation times (>5 min before adding to resin) and keep the reaction at room temperature unless otherwise required.

Solubility issues: If K-Oxyma does not dissolve readily, warm the DMF slightly (to 40 °C) or switch to NMP. Always verify complete dissolution before use.

Low yield after cleavage: Verify resin loading, check that all couplings were complete, and confirm that the cleavage cocktail is appropriate for the protecting groups employed.

Safety and Storage

Safety: K-Oxyma is considered a non-explosive alternative to HOBt. However, standard laboratory safety precautions apply: wear appropriate PPE (lab coat, gloves, safety glasses). Consult the Safety Data Sheet (SDS) before use. DMF and other SPPS solvents are toxic and should be handled in a well-ventilated fume hood.

Storage: Store K-Oxyma in a cool, dry place, tightly sealed, away from moisture and light. Refer to the product label and SDS for specific storage temperature recommendations. Check with Aladdin Scientific (SKU: K468794) for current storage specifications.

Disposal: Dispose of waste reagents and solvents in accordance with local institutional and regulatory requirements for chemical waste.

Frequently asked questions

What is K-Oxyma and how does it differ from Oxyma Pure?

K-Oxyma is the potassium salt of Oxyma Pure (ethyl 2-cyano-2-(hydroxyimino)acetate). The potassium salt form may offer improved solubility in certain SPPS reaction conditions compared to the parent free-acid Oxyma Pure, while retaining the same key advantages of low racemisation risk and non-explosive classification.

Is K-Oxyma safe to use compared to HOBt?

Yes, K-Oxyma is generally regarded as a safer alternative to HOBt because it is classified as non-explosive. HOBt can be classified as explosive under certain conditions and may be subject to shipping and storage restrictions. Always consult the SDS for both reagents and follow institutional safety guidelines.

What coupling activators are compatible with K-Oxyma?

K-Oxyma is most commonly used with carbodiimide-based activators such as DIC (diisopropylcarbodiimide) or DCC (dicyclohexylcarbodiimide). It can also be used alongside uronium-based reagents. The choice of activator may depend on the specific peptide sequence, scale of synthesis, and instrument platform employed.

How do I monitor coupling completeness when using K-Oxyma?

The Kaiser test (ninhydrin test) is the standard method for monitoring coupling of primary amine-containing residues; blue-coloured resin beads indicate incomplete coupling. For secondary amines (e.g., proline), use the chloranil test instead. Colourless or yellow beads in the respective test indicate successful coupling.

What solvents are recommended for dissolving K-Oxyma?

K-Oxyma is typically dissolved in DMF (N,N-dimethylformamide) or NMP (N-methylpyrrolidone), which are the standard solvents in SPPS. If solubility is problematic at room temperature, gentle warming to approximately 40 °C may assist dissolution. Ensure complete dissolution before use.

References

1. El-Faham, A.; Albericio, F. Peptide Coupling Reagents, More than a Letter Soup. Chemical Reviews 2011, 111 (11), 6557–6602. doi:10.1021/cr100048w
2. Subirós-Funosas, R.; Prohens, R.; Barbas, R.; El-Faham, A.; Albericio, F. Oxyma: An Efficient Additive for Peptide Synthesis to Replace the Benzotriazole-Based HOBt and HOAt with a Lower Risk of Explosion. Chemistry – A European Journal 2009, 15 (37), 9394–9403. doi:10.1002/chem.200900614
3. Sigma-Aldrich Product Page: Potassium (Z)-2-cyano-2-(hydroxyimino)acetate (K-Oxyma), Product Number 776874.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.